304 related articles for article (PubMed ID: 27814963)
1. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.
Denny L; de Sanjose S; Mutebi M; Anderson BO; Kim J; Jeronimo J; Herrero R; Yeates K; Ginsburg O; Sankaranarayanan R
Lancet; 2017 Feb; 389(10071):861-870. PubMed ID: 27814963
[TBL] [Abstract][Full Text] [Related]
2. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
3. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
Okeah BO; Ridyard CH
Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
[TBL] [Abstract][Full Text] [Related]
4. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
5. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
6. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
Campos NG; Sharma M; Clark A; Lee K; Geng F; Regan C; Kim J; Resch S
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():47-56. PubMed ID: 28691334
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
8. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
[TBL] [Abstract][Full Text] [Related]
9. The next steps in cervical screening.
Sankaranarayanan R; Qiao YL; Keita N
Womens Health (Lond); 2015 Mar; 11(2):201-12. PubMed ID: 25776294
[TBL] [Abstract][Full Text] [Related]
10. Cancer screening and early diagnosis in low and middle income countries : Current situation and future perspectives.
Mandal R; Basu P
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1505-1512. PubMed ID: 30353287
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening in low- and middle-income countries.
Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M
Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259
[TBL] [Abstract][Full Text] [Related]
12. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.
Ladner J; Besson MH; Audureau E; Rodrigues M; Saba J
BMC Health Serv Res; 2016 Oct; 16(1):575. PubMed ID: 27737666
[TBL] [Abstract][Full Text] [Related]
13. Innovative approaches to cervical cancer screening in low- and middle-income countries.
Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
[TBL] [Abstract][Full Text] [Related]
14. Cervical Cancer Prevention in Low- and Middle-Income Countries.
Allanson ER; Schmeler KM
Clin Obstet Gynecol; 2021 Sep; 64(3):501-518. PubMed ID: 34120126
[TBL] [Abstract][Full Text] [Related]
15. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
16. HPV vaccination: The most pragmatic cervical cancer primary prevention strategy.
Sankaranarayanan R
Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 1():S33-5. PubMed ID: 26433502
[TBL] [Abstract][Full Text] [Related]
17. Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review.
Murfin J; Irvine F; Meechan-Rogers R; Swift A
J Clin Nurs; 2020 Feb; 29(3-4):393-415. PubMed ID: 31713934
[TBL] [Abstract][Full Text] [Related]
18. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women?
Liu X; Feng A; Cui Y; Tobe RG
Biosci Trends; 2013 Aug; 7(4):159-67. PubMed ID: 24056165
[TBL] [Abstract][Full Text] [Related]
19. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
20. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
